三星医疗：公司对控股子公司提供的担保总额为人民币约97.48亿元

Group 1 - Samsung Medical's revenue composition for 2024 is as follows: manufacturing accounts for 76.16%, medical services for 22.31%, other businesses for 1.48%, and financial services for 0.04% [1] - As of the announcement date, Samsung Medical has provided guarantees totaling approximately RMB 9.748 billion to its controlling subsidiaries, which represents 80.69% of the company's net assets attributable to shareholders for 2024 [3] - The actual guarantee balance for controlling subsidiaries is approximately RMB 5.619 billion, accounting for 46.51% of the company's net assets attributable to shareholders for 2024 [3]